Neurocrine Biosciences | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.61B 6.98B 2025-03
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
ALKERMES USD 292.72M 25.42M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Biogen USD 2.12B 106.5M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Cytokinetics USD 155.97M 14.7M 2024-12
Dynavax Technologies USD 73.66M 3.12M 2024-12
Exelixis USD 403.55M 82K 2025-01
Gilead Sciences USD 4.43B 687M 2025-03
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Prothena USD 67.02M 463K 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Repligen USD 162.59M 41.45M 2025-03
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Neurocrine Biosciences Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.